Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
Authors
Keywords
-
Journal
BRITISH JOURNAL OF DERMATOLOGY
Volume 173, Issue 4, Pages 949-961
Publisher
Wiley
Online
2015-07-07
DOI
10.1111/bjd.14018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response
- (2015) J.E. Signorovitch et al. BRITISH JOURNAL OF DERMATOLOGY
- Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial
- (2015) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results
- (2015) Alexa B. Kimball et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
- (2015) Hervé Bachelez et al. LANCET
- Risk of herpes zoster in psoriatic patients undergoing biologic treatment
- (2014) Yoshinori Umezawa et al. JOURNAL OF DERMATOLOGY
- Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
- (2014) Mark G. Lebwohl et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Nail Psoriasis, the unknown burden of disease
- (2014) K.M.G. Klaassen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
- (2014) Kevin L. Winthrop et al. Arthritis & Rheumatology
- Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study*
- (2013) Iain B McInnes et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
- (2013) J. Schmitt et al. BRITISH JOURNAL OF DERMATOLOGY
- Jakpot! New small molecules in autoimmune and inflammatory diseases
- (2013) Kamran Ghoreschi et al. EXPERIMENTAL DERMATOLOGY
- The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions
- (2013) L. Adelzadeh et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States
- (2013) April W. Armstrong et al. JAMA Dermatology
- Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Risk of Herpes zoster in patients with psoriasis treated with biologic drugs
- (2011) J. Dreiher et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Nail psoriasis in Germany: epidemiology and burden of disease
- (2010) M. Augustin et al. BRITISH JOURNAL OF DERMATOLOGY
- Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents
- (2010) Wolfgang Weger BRITISH JOURNAL OF PHARMACOLOGY
- British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009
- (2009) C.H. Smith et al. BRITISH JOURNAL OF DERMATOLOGY
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- European S3-Guidelines on the systemic treatment of psoriasis vulgaris
- (2009) D Pathirana et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
- (2007) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More